Baxter International Inc. (BAX), headquartered in Deerfield, Illinois, develops and provides a portfolio of healthcare ...

Baxter calculates forward-looking non-GAAP financial measures based on forecasts that omit certain amounts that would be included in GAAP financial measures. For instance, forward-looking operational ...

Q4 sales performance exceeded guidance, driven by better-than-expected sales in Medical Products, Kidney Care, Pharmaceuticals. Baxter reported improved profitability in fourth quarter. Brand New ...

Baxter International Inc. reported its fourth-quarter 2025 earnings, revealing earnings per share (EPS) of $0.44, missing the forecast of $0.54. Despite a revenue surprise of 4.58% with actual revenue ...

As Baxter International Inc (NYSE:BAX) prepares to release its second-quarter 2023 financial results on July 27, Stifel analyst writes it is an opportune time for investors to consider owning BAX ...

Andrew Hider, President, Chief Executive Officer, addressed his first earnings call, emphasizing both the foundational strengths and the urgent need for improvement at Baxter. He noted, "We are not ...

Baxter International (BAX) reported $2.84 billion in revenue for the quarter ended September 2025, representing a year-over-year increase of 5%. EPS of $0.69 for the same period compares to $0.80 a ...

Gift Article 10 Remaining As a subscriber, you have 10 articles to gift each month. Gifting allows recipients to access the article for free. On the heels of a major companywide restructuring, Baxter ...